Literature DB >> 7171453

Endothelial-cell proliferation in experimental tumours.

J Denekamp, B Hobson.   

Abstract

The proliferation characteristics of vascular endothelium have been studied in 131 individual experimental tumours, representing 18 transplanted tumour lines. The labelling index (LI) is high in most tumours, with a mean value of 0.9%, regardless of the growth rate of the tumours, or whether different tumour types are considered or individual tumours from within one line are studied in detail. A similar high LI value has been found by others for a human tumour. These high LI values may even underestimate the proliferation in new capillary buds. The high proliferative index of tumour endothelium is in marked contrast with the previously reported low 3HTdR uptake into normal tissue blood vessels. It seems likely that it is the type of new vessels formed that will influence tumour growth rates more than the simple rate of endothelial-cell proliferation. The large difference between the proliferation characteristics of tumour endothelium and normal tissue endothelium, recently identified as a possible approach for tumour therapy, has now been confirmed for a range of animal tumours and a human tumour.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7171453      PMCID: PMC2011157          DOI: 10.1038/bjc.1982.263

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  Autoradiographic investigations of glial proliferation in the brain of adult mice. II. Cycle time and mode of proliferation of neuroglia and endothelial cells.

Authors:  H Korr; B Schultze; W Maurer
Journal:  J Comp Neurol       Date:  1975-04-15       Impact factor: 3.215

2.  Quantitative techniques for study of the anatomy and function of small blood vessels in tumors.

Authors:  I F Tannock; G G Steel
Journal:  J Natl Cancer Inst       Date:  1969-05       Impact factor: 13.506

3.  Morphometric analyses of the microvasculature of tumors during growth and after x-irradiation.

Authors:  D E Hilmas; E L Gillette
Journal:  Cancer       Date:  1974-01       Impact factor: 6.860

4.  In vitro and in vivo labelling of animal tumours with tritiated thymidine.

Authors:  J Denekamp; R F Kallman
Journal:  Cell Tissue Kinet       Date:  1973-05

5.  The relationship between the 'cell loss factor' and the immediate response to radiation in animal tumours.

Authors:  J Denekamp
Journal:  Eur J Cancer       Date:  1972-06       Impact factor: 9.162

6.  The cellular proliferation kinetics of animal tumors.

Authors:  J Denekamp
Journal:  Cancer Res       Date:  1970-02       Impact factor: 12.701

7.  Population kinetics of carcinoma cells, capillary endothelial cells, and fibroblasts in a transplanted mouse mammary tumor.

Authors:  I F Tannock
Journal:  Cancer Res       Date:  1970-10       Impact factor: 12.701

8.  Microcirculation of tumors. I. Anatomy, function, and necrosis.

Authors:  P Rubin; G Casarett
Journal:  Clin Radiol       Date:  1966-07       Impact factor: 2.350

9.  The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour.

Authors:  I F Tannock
Journal:  Br J Cancer       Date:  1968-06       Impact factor: 7.640

10.  Isolation of a tumor factor responsible for angiogenesis.

Authors:  J Folkman; E Merler; C Abernathy; G Williams
Journal:  J Exp Med       Date:  1971-02-01       Impact factor: 14.307

View more
  56 in total

Review 1.  Therapeutic inhibition of angiogenesis.

Authors:  Hua-Tang Zhang; Roy Bicknell
Journal:  Mol Biotechnol       Date:  2003-10       Impact factor: 2.695

Review 2.  Endothelial cell heterogeneity.

Authors:  William C Aird
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 3.  Drug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systems.

Authors:  Daniel J Sobczynski; Margaret B Fish; Catherine A Fromen; Mariana Carasco-Teja; Rhima M Coleman; Omolola Eniola-Adefeso
Journal:  Ther Deliv       Date:  2015-08-14

4.  Acute tumor response to ZD6126 assessed by intrinsic susceptibility magnetic resonance imaging.

Authors:  Simon P Robinson; Tammy L Kalber; Franklyn A Howe; Dominick J O McIntyre; John R Griffiths; David C Blakey; Lynsey Whittaker; Anderson J Ryan; John C Waterton
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

5.  Differential effects of thalidomide on angiogenesis and tumor growth in mice.

Authors:  A V Belo; M A Ferreira; A A Bosco; R D Machado; S P Andrade
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

6.  Tumor vessel compression hinders perfusion of ultrasonographic contrast agents.

Authors:  Mirco Galiè; Mirko D'Onofrio; Maura Montani; Augusto Amici; Laura Calderan; Pasquina Marzola; Donatella Benati; Flavia Merigo; Cristina Marchini; Andrea Sbarbati
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

7.  Support of a free radical mechanism for enhanced antitumor efficacy of the microtubule disruptor OXi4503.

Authors:  Lori Rice; Christine Pampo; Sharon Lepler; Amyn M Rojiani; Dietmar W Siemann
Journal:  Microvasc Res       Date:  2010-10-23       Impact factor: 3.514

8.  Tempol prevents impairment of the endothelial cell wound healing response caused by ionising radiation.

Authors:  S J Braunhut; D Medeiros; L Lai; E A Bump
Journal:  Br J Cancer Suppl       Date:  1996-07

Review 9.  Vascular endothelial growth factor and other signaling pathways in developmental and pathologic angiogenesis.

Authors:  Gavin Thurston; Nicholas W Gale
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

Review 10.  Vascular attack as a therapeutic strategy for cancer.

Authors:  J Denekamp
Journal:  Cancer Metastasis Rev       Date:  1990-11       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.